These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2820404)
21. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells. Newman MJ; Lane EA; Nugent MA; Racker E Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539 [TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system. Kaplan PL; Anderson M; Ozanne B Proc Natl Acad Sci U S A; 1982 Jan; 79(2):485-9. PubMed ID: 6952201 [TBL] [Abstract][Full Text] [Related]
23. Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha. Myrdal SE; Twardzik DR; Auersperg N J Cell Biol; 1986 Apr; 102(4):1230-4. PubMed ID: 3007529 [TBL] [Abstract][Full Text] [Related]
24. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745 [TBL] [Abstract][Full Text] [Related]
25. Immunochemical comparison of transformation-associated protein and secreted phosphoprotein. Chan JC; Scanlon M; Denhardt DT; Singh K; Mukherjee BB; Farach-Carson MC; Butler WT Int J Cancer; 1990 Nov; 46(5):864-70. PubMed ID: 2228315 [TBL] [Abstract][Full Text] [Related]
26. Decrease in epidermal growth factor receptor levels and production of material enhancing epidermal growth factor binding accompany the temperature-dependent changes from normal to transformed phenotype. Guinivan P; Ladda RL Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3377-81. PubMed ID: 315064 [TBL] [Abstract][Full Text] [Related]
27. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus. Jullien P; Berg TM; de Lannoy C; Lawrence DA J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442 [TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor production by chemically transformed cells. Moses HL; Branum EL; Proper JA; Robinson RA Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069 [TBL] [Abstract][Full Text] [Related]
29. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914 [TBL] [Abstract][Full Text] [Related]
30. Transformation-related growth factors and their receptors. Bregman MD; Sipes NJ Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097 [TBL] [Abstract][Full Text] [Related]
31. An agent or agents produced by virus-transformed cells cause unregulated ruffling in untransformed cells. Myrdal SE; Auersperg N J Cell Biol; 1986 Apr; 102(4):1224-9. PubMed ID: 3007528 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Todaro GJ; Fryling C; De Larco JE Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5258-62. PubMed ID: 6254071 [TBL] [Abstract][Full Text] [Related]
33. Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-beta 1 in normal rat kidney (NRK) cells: decreased PAI-1 expression in transformed NRK cells. Newman MJ; Lane EA; Iannotti AM; Nugent MA; Pepinsky RB; Keski-Oja J Endocrinology; 1990 Jun; 126(6):2936-46. PubMed ID: 2190800 [TBL] [Abstract][Full Text] [Related]
34. A high-molecular-weight PDGF-like factor secreted by v-sis transformed cells leads to growth stimulation and transformation. Klein R; Thiel HJ Oncogene Res; 1988 May; 2(4):311-24. PubMed ID: 2840622 [TBL] [Abstract][Full Text] [Related]
35. Changes in cell surface charge and transmembrane potential accompanying neoplastic transformation of rat kidney cells. Price JA; Pethig R; Lai CN; Becker FF; Gascoyne PR; Szent-Györgyi A Biochim Biophys Acta; 1987 Apr; 898(2):129-36. PubMed ID: 3828335 [TBL] [Abstract][Full Text] [Related]
36. Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors. Ozanne B; Fulton RJ; Kaplan PL J Cell Physiol; 1980 Oct; 105(1):163-80. PubMed ID: 6253509 [TBL] [Abstract][Full Text] [Related]
37. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A. Yamada Y; Serrero G J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884 [TBL] [Abstract][Full Text] [Related]
38. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655 [TBL] [Abstract][Full Text] [Related]
39. Polypeptide growth factors: roles in normal and abnormal cell growth. Deuel TF Annu Rev Cell Biol; 1987; 3():443-92. PubMed ID: 3318882 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants. Weiland E; Thiel HJ J Gen Virol; 1985 Sep; 66 ( Pt 9)():1863-72. PubMed ID: 2993478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]